FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018676892> ?p ?o ?g. }

• W2018676892 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCNanoparticles represent a novel class of agents for cancer treatment. In the present study, we examined the effects of epidermal growth factor receptor (EGFR)-targeted hybrid plasmonic magnetic nanoparticles (NP) on non-small cell lung cancer (NSCLC) cells. The nanoparticles (NP) consisted of a paramagnetic iron core that is surrounded by a gold layer and is functionalized with monoclonal anti-EGFR antibody (C225) or control rabbit IgG antibody (IgG). The nanoparticles were tested against a panel of human lung cancer cells that were mutant (HCC827, H1819), wild-type (H1299) or null (H520) for EGFR and compared to EGFR-positive normal fibroblasts (MRC9, WI38) and normal human bronchial epithelial (NHBE) cells. Treatment of tumor cells with C225-NP resulted in a strong and significant inhibitory effect of cell growth compared to normal cells. C225-NP-mediated inhibitory effect was observed only in EGFR-positive tumor cells (HCC827, H1819, H1299) but not in EGFR-null H520 cells. EGFR-mutant cells (HCC827) were the most sensitive to C225-NP. No significant growth inhibitory effects were observed in IgG-NP-treated cells when compared to untreated cells. Molecular analysis showed C225-NP selectively inhibited phosphorylated p-EGFR protein expression and EGFR-mediated signal transduction resulting in induction of autophagy followed by apoptosis. Autophagy occurred as early as twenty-four hours after treatment with an increase in LC3-II content and autophagic vacuoles observed by Western blotting and electron microscopy respectively. Apoptosis as determined by flow cytometry and Western blotting showed an increase in the number of sub-G1 population cells and cleavage of caspase-3 and PARP in C225-NP-treated cells. Optical images determined by dark-field microscopy showed an increase in the concentration of C225-NP bound to EGFR-expressing NSCLC cells but not EGFR-null NSCLC cells. C225-NP exhibited 2-7 fold higher efficiency in induction of cell killing in comparison with the same amount of free C225 antibody. Free C225 antibody did not induce autophagy in cells. Investigation into how C225-NP but not C225 antibody or NP-alone triggers autophagy and initiates apoptosis showed induction of a DNA damage response as evidenced by the formation of γH2AX foci in C225-NP-treated cells. Minimal to no γH2AX foci were observed in cells that were untreated, treated with C225 antibody or NP-alone or treated with IgG-NP. Our data show that EGFR specific NP selectively induced cytotoxic effects in EGFR-expressing lung cancer cells via a novel cell-death mechanism that is not characteristic of the free antibody thus increasing efficacy of therapy.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3505." @default.
• W2018676892 created "2016-06-24" @default.
• W2018676892 creator A5002192039 @default.
• W2018676892 creator A5005161326 @default.
• W2018676892 creator A5020188029 @default.
• W2018676892 creator A5027152610 @default.
• W2018676892 creator A5033556493 @default.
• W2018676892 creator A5041501326 @default.
• W2018676892 creator A5060428720 @default.
• W2018676892 creator A5068736204 @default.
• W2018676892 creator A5082208358 @default.
• W2018676892 date "2010-04-15" @default.
• W2018676892 modified "2023-09-23" @default.
• W2018676892 title "Abstract 3505: EGFR-targeted hybrid plasmonic magnetic nanoparticles induce autophagy and apoptosis through DNA damage in non-small cell lung cancer cells" @default.
• W2018676892 doi "https://doi.org/10.1158/1538-7445.am10-3505" @default.
• W2018676892 hasPublicationYear "2010" @default.
• W2018676892 type Work @default.
• W2018676892 sameAs 2018676892 @default.
• W2018676892 citedByCount "0" @default.
• W2018676892 crossrefType "proceedings-article" @default.
• W2018676892 hasAuthorship W2018676892A5002192039 @default.
• W2018676892 hasAuthorship W2018676892A5005161326 @default.
• W2018676892 hasAuthorship W2018676892A5020188029 @default.
• W2018676892 hasAuthorship W2018676892A5027152610 @default.
• W2018676892 hasAuthorship W2018676892A5033556493 @default.
• W2018676892 hasAuthorship W2018676892A5041501326 @default.
• W2018676892 hasAuthorship W2018676892A5060428720 @default.
• W2018676892 hasAuthorship W2018676892A5068736204 @default.
• W2018676892 hasAuthorship W2018676892A5082208358 @default.
• W2018676892 hasConcept C121608353 @default.
• W2018676892 hasConcept C126322002 @default.
• W2018676892 hasConcept C142724271 @default.
• W2018676892 hasConcept C153911025 @default.
• W2018676892 hasConcept C159654299 @default.
• W2018676892 hasConcept C185592680 @default.
• W2018676892 hasConcept C190283241 @default.
• W2018676892 hasConcept C203014093 @default.
• W2018676892 hasConcept C2776256026 @default.
• W2018676892 hasConcept C2779438470 @default.
• W2018676892 hasConcept C502942594 @default.
• W2018676892 hasConcept C553184892 @default.
• W2018676892 hasConcept C55493867 @default.
• W2018676892 hasConcept C71924100 @default.
• W2018676892 hasConcept C81729549 @default.
• W2018676892 hasConcept C86803240 @default.
• W2018676892 hasConcept C96232424 @default.
• W2018676892 hasConceptScore W2018676892C121608353 @default.
• W2018676892 hasConceptScore W2018676892C126322002 @default.
• W2018676892 hasConceptScore W2018676892C142724271 @default.
• W2018676892 hasConceptScore W2018676892C153911025 @default.
• W2018676892 hasConceptScore W2018676892C159654299 @default.
• W2018676892 hasConceptScore W2018676892C185592680 @default.
• W2018676892 hasConceptScore W2018676892C190283241 @default.
• W2018676892 hasConceptScore W2018676892C203014093 @default.
• W2018676892 hasConceptScore W2018676892C2776256026 @default.
• W2018676892 hasConceptScore W2018676892C2779438470 @default.
• W2018676892 hasConceptScore W2018676892C502942594 @default.
• W2018676892 hasConceptScore W2018676892C553184892 @default.
• W2018676892 hasConceptScore W2018676892C55493867 @default.
• W2018676892 hasConceptScore W2018676892C71924100 @default.
• W2018676892 hasConceptScore W2018676892C81729549 @default.
• W2018676892 hasConceptScore W2018676892C86803240 @default.
• W2018676892 hasConceptScore W2018676892C96232424 @default.
• W2018676892 hasLocation W20186768921 @default.
• W2018676892 hasOpenAccess W2018676892 @default.
• W2018676892 hasPrimaryLocation W20186768921 @default.
• W2018676892 hasRelatedWork W2012293141 @default.
• W2018676892 hasRelatedWork W2165491284 @default.
• W2018676892 hasRelatedWork W2369334077 @default.
• W2018676892 hasRelatedWork W2379228267 @default.
• W2018676892 hasRelatedWork W2381360837 @default.
• W2018676892 hasRelatedWork W2383441029 @default.
• W2018676892 hasRelatedWork W2383446536 @default.
• W2018676892 hasRelatedWork W2384290802 @default.
• W2018676892 hasRelatedWork W2478844847 @default.
• W2018676892 hasRelatedWork W2497346098 @default.
• W2018676892 hasRelatedWork W2517051792 @default.
• W2018676892 hasRelatedWork W2565958605 @default.
• W2018676892 hasRelatedWork W2789869728 @default.
• W2018676892 hasRelatedWork W2804105518 @default.
• W2018676892 hasRelatedWork W2920826237 @default.
• W2018676892 hasRelatedWork W2980959169 @default.
• W2018676892 hasRelatedWork W3032861601 @default.
• W2018676892 hasRelatedWork W3142373004 @default.
• W2018676892 hasRelatedWork W3170974978 @default.
• W2018676892 hasRelatedWork W2733059643 @default.
• W2018676892 isParatext "false" @default.
• W2018676892 isRetracted "false" @default.
• W2018676892 magId "2018676892" @default.
• W2018676892 workType "article" @default.